Analyst Ratings for VYNE Therapeutics (VYNE)

VYNE Rating Summary

  |   Expand Research on VYNE
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: N/A
Rating Score: 0 / 10   Percentile Rank: 0%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/31/2025 BTIG Julian Harrison Downgrade Neutral
(Buy)
N/A
(N/A)
1.44
(0.66)
-54.17% Details
7/30/2025 H.C. Wainwright Joseph Pantginis Downgrade Neutral
(Buy)
N/A
(N/A)
1.44
(0.66)
-54.17% Details